Advertisement
Home 2019

Yearly Archives: 2019

January 2019 Briefing – Neurology

0
Here are what the editors at HealthDay consider to be the most important developments in Neurology for January 2019. This roundup includes the latest...

January 2019 Briefing – Infectious Disease

0
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for January 2019. This roundup includes the...

January 2019 Briefing – HIV & AIDS

0
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for January 2019. This roundup includes...

January 2019 Briefing – Gastroenterology

0
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for January 2019. This roundup includes the latest...

January 2019 Briefing – Family Practice

0
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for January 2019. This roundup includes the...

January 2019 Briefing – Diabetes & Endocrinology

0
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for January 2019. This roundup includes...

January 2019 Briefing – Dermatology

0
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for January 2019. This roundup includes the latest...

January 2019 Briefing – Cardiology

0
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for January 2019. This roundup includes the latest...

January 2019 Briefing – Allergy

0
Here are what the editors at HealthDay consider to be the most important developments in Allergy for January 2019. This roundup includes the latest...
The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the U.S. Food and Drug Administration.

FDA Approves First Generic Version of Advair for Asthma, COPD

0
Medication approved to treat children aged 4 or older with asthma, adults with asthma or COPD